The concept of typical and atypical chronic lymphocytic leukaemia

Leukemia and Lymphoma

Volumn 33, Issue 1-2, 1999, Pages 33-45

  Criel, Arnold ^a   Michaux, Lucienne ^b   De Wolf Peeters, Chris ^b  

^a Department of Haematology ^*  (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Atypical CLL; Chronic lymphocytic leukaemia; Clinical features; Cytogenetics; Immunophenotype; Prognosis; Typical CLL

Indexed keywords

CHRONIC LYMPHATIC LEUKEMIA; CYTOGENETICS; DISEASE CLASSIFICATION; HUMAN; IMMUNOPHENOTYPING; MORPHOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0032973291     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909093723     Document Type: Review

References (80)

1. Dighiero, G., Travade, P., Chevret, S., Fenaux, P., Chastang, C. and Binet, J.L. (1991). The French Cooperative Group on CLL: B-cell chronic lymphocytic leukemia: present status and future directions. Blood. 78, 1901-1914.
2. Cheson, B.D. (1993). Chronic lymphocytic leukemia: staging and prognostic factors. In Cheson B.D. (ed): Chronic lymphocytic leukemia. Scientific Advances and Clinical Developments, .pp 253-280. New York: Marcel Dekker.
3. Rozman, C. and Montserrat, E. (1995). Chronic lymphocytic leukemia: current concepts. The New England Journal of Medicine, 19, 1052-1057.
4. Rai, K.R., Sawitsky, A., Cronkite, E.P., Chanana, A.B., Leey, R.N. and Pasternack, B.S. (1975). Clinical staging of chronic lymphocytic leukemia. Blood, 46, 219-234.
5. Rai, K.R. (1987) A critical analysis of staging in CLL. In Gale, R.P., Rai, K.R. (eds): Chronic lymphocytic leukemia. Recent progress and future direction. New York, NY, Liss. A.R., 59, 253-264.
6. Binet, J.L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., Vaugier, G., Potron, G., Colona, P., Thomas. M., Tchernia, G., Jacquillat, C., Boivin, P., Lesty, C., Duault, M.T. and Monconduit, M. (1981). A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer, 48, 198-206.
7. Galton, D.A.G. (1966). The pathogenesis of chronic lymphocytic leukemia. Canadian Medical Association Journal, 94, 1005-1010.
8. Juliusson, G., Oscier, D.G., Fitchett, M., Fiona, M., Ross, F., Stockdil, G., Mackie, M.J., Parker, A.C., Castoldi, G.L., Cunco, A., Knuutila, S., Elonen, E. and Gahrton, G. (1990). Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. New England Journal of Medicine, 323, 720-724.
9. Montserrat, E., Sánchez-Bisonó, J., Viñolas N. and Rozman, C. (1986). Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance. British Journal of Haematology, 62, 567-575.
10. Rozman, C., Hernández-Nieto, L., Montserrat, E. and Brugués, R. (1981). Prognostic significance of bone-marrow patterns in chronic lymphocytic leukaemia. British Journal of Haematology, 47, 529-537.
11. Rozman, C., Montserrat, E., Rodriguez-Fernandez, J.M., Ayats, R., Vallespi, T., Rios, A., Padros, D., Morey, M., Gomis, F., Alcala, A., Gutiérrez, M., Maldonado, J., Gonzalez, C., Giralt, M., Hernandez-Nieto, L., Cabrena, A. and Fernandez-Ranada, J.M. (1984). Bone marrow histology pattern - the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. Blood, 64, 642-648.
12. Bennett, J.M., Catovsky, D., Daniel, M.-T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. and Sultan, C. (1989). The French-American-British (FAB) cooperative study group: Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. Journal of Clinical Pathology, 42, 567-584.
13. Bird, M.L., Ueshima, Y., Rowley, J.D., Haren, J.M. and Vardiman, J.W. (1989), Chromosome abnormalities in B-cell chronic lymphocytic leukemia and their clinical correlations. Leukemia, 3, 182-191.
14. Que, T.H., Garcia-Marco, J., Ellis, J., Matutes, E., Brito Babapulle, V., Boyle, S. and Catovsky, D. (1993). Trisomy 12 in chronic lymphocytic leukemia detected by fluorescensee in situ hybridization: analysis by stage. immunophenotype and morphology. Blood, 82, 671-676.
15. Criel, A., Wlodarska, I., Meeus, P., Stul, M., Louwagie, A., Van Hoof, A., Hidajat, M., Mecucci, C. and Van den Bcrghe, H. (1994). Trisomy 12 is uncommon in typical chronic lymphocytic leukaemias. British Journal of Haematology, 87, 523-528.
16. Matutes, E., Oscier, D., Garcia-Marco, J., Ellis, J., Copplestone, A., Gillingham, R., Hamblin, T., Lens, D., Swansbury, G. and Catovsky, D. (1996). Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. British Journal of Haematology, 92, 382-388.
17. Tabernero, M.D., San Miguel, J.F., Garcia, J.L., Garcia-Isidoro, M., Wiegant, J., Ciudad, J., Gonzalez, M., Rios, A., Raap, A. and Orfao, A. (1995). Clinical, biological and immunophenotypical characteristics of B-cell chronic lymphocytic leukemia with trisomy 12 by fluorescence in situ hybridization. Cytometry, 22, 217-222.
18. Knauf, W.U., Knuutila, S., Zeigmeister, B. and Thiel, E. (1995). Trisomy 12 in B-cell chronic lymphocytic leukemia: correlation with advanced disease, atypical morphology, high levels of sCD25, and with refractoriness to treatment. Leukemia and Lymphoma, 19, 289-294.
19. Woessner, S., Sole, F., Perez-Losada, A., Florensa, L. and Vila, R.M. (1996). Trisomy 12 is a rare cytogenetic finding in typical chronic lymphocytic leukemia. Leukemia Research, 20, 369-374.
20. Finn, W.G., Thangavelu, M., Yelavarthi, K.K., Goolsby, C.L., Tallman, M.S., Traynor, A. and Peterson, L.C. (1996). Karyotype correlates with peripheral blood morphology and immunophenotype in chronic lyniphocytic leukemia. American Journal of Clinical Pathology, 105, 458-467.
21. Melo, J.V., Catovsky, D. and Galton, D.A.G. (1996). The relationship between chronic lymphocytic leukaemia and prolyniphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterisation of an intermediate group. British Journal of Haematology, 63, 377-387.
22. Melo, J.V., Catovsky, D., and Galton, D.A.G. (1986). The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. II. Patterns of evolution of "prolymphocytoid" transformation. British Journal of Haemalology, 64, 77-86.
23. Ghani, A. and Krause, J. (1996). Investigation of cell size and nuclear clefts as prognostic parameters in chronic lymphocytic leukemia. Cancer, 58, 2233-2238.
24. Molica, S. and Alberti, A. (1988). Investigation of nuclear clefts as a prognostic parameter in chronic lymphocytic leukemia. European Journal of Haematology, 41, 62-65.
25. Vallespi, T., Montserrat, E. and Sanz. M.A. (1991). Chronic lymphocytic leukaemia: prognostic value of lymphocyte morphological subtypes. A multivariate survival analysis in 146 patients. British Journal of Haematology, 77, 478-485.
26. Orfao, A., Gonzàlez, M., San Miguel, J., Cañizo, M., Galindo, P., Caballero, M., Jimenez, R. and Borrasca, A. (1988). Clinical and immunological findings in large B-cell chronic lymphocytic leukemia. Clinical Immunology and Immunopathology, 46, 177-185.
27. Dubner, H., Crowley, J. and Schilling, R. (1978). Prognostic value of nucleoli and cell size in chronic lymphocytic leukemia. American Journal of Hematology, 4, 337-341.
28. Melo, J.V., Catovsky, D., Gregory, W.M. and Galton, D.A. (1987). The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. IV. Analysis of survival and prognostic features. British Journal of Haematology, 65, 23-29.
29. Oscier, D.G., Matutes, E., Copplestone, A., Pickering, R.M., Chapman, R., Gillingham, R., Catovsky, D. and Hamblin T.J. (1997). Atypical lymphocyte morphology: an adverse prognostic factor for disease progression in stage a CLL independent of trisomy 12. British Journal of Haematology, 98, 934-939.
30. Zomas, A.P., Matutes, E., Morilla, R., Owusu-Ankomah, K., Scon, B.K. and Catovsky, D. (1996). Expression of the immunoglobulin-associated protein B29 in B-cell disorders with the monoclonal antibody SN8 (CD79b). Leukemia, 10, 1966-1970.
31. Thompson, A.A., Talley, J.A., Do, H.N., Kagan, H.L., Kunkel, L., Berenson, J., Cooper, M.D., Saxon, A. and Wall, R. (1997). Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia. Blood, 90, 1387-1394.
32. Moreau, E.J., Matutes, E., A'Hern, R.P., Morilla, A.M., Morilla, R.M., Owusu-Ankomah, K.A., Seon, B.K. and Catovsky, D. (1997). Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). American Journal of Clinical Pathology, 108, 378-382.
33. Oscier, D.G., Stevens, J., Hamblin, T.J., Pickering, R.M. and Fitchett, M. (1990). Prognostic factors in stage AO B-cell chronic lymphocytic leukaemia. British Journal of Haematology, 76, 348-351.
34. Witzig, T.E., Chin-Yang, L., Tefferi, A. and Katzmann, J. (1994). Measurement of the intensity of cell surface antigen expression in B-cell chronic lymphocytic leukemia. American Journal of clinical pathology. 101, 312-317.
35. Geisler, C.H., Larsen, J.K., Hansen, N.E., Hansen, M.M., Christensen, B.E., Lund, B., Nielsen, H., Plesner, T., Thorling, K., Andersen, E. and Andersen, P.K. (1991). Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood, 78, 1795-1802.
36. Dadmarz, R. and Cawley, J.C. (1988). Heterogeneity of CLL: high CD23 antigen and aIFN receptor expression are features of favourable disease and of cell activation. British Journal of Haematology, 68, 279-282.
37. Kurec, A.S., Threatte, G.A., Gottlieb, A.J., Smith, J.R., Anderson, J. and Davey, F.R. (1992). Immunophenotypic subclassification of chronic lymphocytic leukaemia (CLL). British Journal of Haematology, 81, 45-51.
38. De Rossi, G., Mauro, F.R., Lo Coco, F., Caruso, R., Niscola, P., Pasqualetti, D. and Mandelli, F. (1993). CD5 negative lymphocytosis mimicking typical B-chronic lymphocytic leukaemia. Description of 26 cases. Nouvelle Revue Française d'Hématologie, 35, 451-455
39. Gagro, A., Dasic, G., Sabioncello, A., Rabatic, S., Reckzeh, B., Havemann, K., Kardum, I., Jaksic, B. and Vitale, B. (1997). Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia. Leukemia and Lymphoma, 25, 301-311.
40. Ghosh, K., Sivakumaran, M. and Wood, J., (1993). Aberrant CD8 antigen expression in a patient with B-chronic lymphocytic leukaemia showing unusual disease progression. British Journal of Haematology, 85, 205-206.
41. Tefferi, A., Li, C.Y. and Phyliky, R.L. (1989). Correlation of clinical outcome with the degree of surface immunoglobulin (slg) expression in B-cell chronic lymphocytic leukemia. American Journal of clinical pathology, 92, 82-85.
42. Molica, S., Dattilo, A. and Levato, D. (1997). Clinical relevance of the intensity of CD20 antigen in B-cell chronic lymphocytic leukaemia. Hematology and Cell Therapy, 39, suppl I, S65-S67.
43. Morabito, F., Prasthofer, E.F., Dunlap, N.E., Grossi, C.E. and Tilden, A.B. (1987). Expression of myelomonocytic antigens on chronic lymphocytic leukemia B-cells correlates with their ability to produce interleukin 1. Blood, 70, 1750-1757.
44. + chronic B-cell leukemias and the identification of novel peripheral blood B-cell subsets with chronic lymphoid leukemia immunophenotypes. Blood, 76, 123-130.
45. Hanson, C.A., Gribbin, T.E., Schnitzer, B., Schlegelmilch, J.A., Mitchell, B.S. and Stoolman, L.M. (1990). CD11c (Leu-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia. Blood, 76, 2360-2367.
46. Hernandez, J.M., Mecucci, C., Criel, A., Meeus, P., Michaux, L., Van Hoof, A., Verhoef, G., Louwagie, A., Scheiff, J.M., Michaux, J.L., Boogaerts, M. and Van den Berghe, H. (1995). Cytogenetic analysis of B-cell chronic lymphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria. Leukemia, 9, 2140-2146.
47. Bigoni, R., Cuneo, A., Roberti, M.G., Bardi, A. Rigolin, G.M., Piva, N., Scapoli, G., Spanedda, R., Negrini, M., Bullrich, F., Veronese, M.L., Croce, C.M. and Castoldi, G. (1997). Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study. Leukemia, 11, 1933-1940.
48. Fegan, C., Robinson, H., Thompson, P., Whittaker, J.A. and White, D. (1995). Karyotypic evolution in CLL: identification of a new sub-group of patients with deletions of 11q and advanced or progressive disease. Leukemia, 9, 2003-2008.
49. Oscier, D.G. (1994). Cytogenetic and molecular abnormalities in chronic lymphocytic leukaemia. Blood Reviews, 8, 88-97.
50. Arif, M., Tanaka, K., Asou, H., Ohno, R. and Kamada, N. (1995). Independent clones of trisomy 12 and retinoblastoma gene deletion in Japanese B-cell chronic lymphocytic leukemia, detected by fluorescence in situ hybridization. Leukemia, 9, 1822-1827.
51. Mould, S., Gardiner, A., Corcoran, M. and Oscier, D.G. (1996). Trisomy 12 and structural abnormalities of 13q14 occurring in the same clone in chronic lymphocytic leukaemia. British Journal of Haematology, 92, 389-392.
52. Garcia-Marco, J.A., Price, C.M. and Catovsky, D. (1997). Interphase cytogenetics in chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics, 94, 52-58.
53. Dierlamm, J., Michaux, L., Criel, A., Wlodarska, I., Van den Berghe, H. and Hossfeld K. (1997). Genetic abnormalities in chronic lymphocytic leukemia and their clinical and prognostic implications. Cancer Genetics and Cytogenetics, 94, 27-35.
54. Robert, K.H., Gahrton, G., Friberg, K., Zech, L. and Nilsson, B. (1982). Extra chromosome 12 and prognosis in chronic lymphocytic leukaemia. Scandinavian Journal of Haematology, 28, 163-168.
55. Sadamori, N., Han, T., Minowada, J. and Sandberg, A.A. (1984). Clinical significance of cytogenetic findings in untreated patients with B-cell chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics, 11, 45-51.
56. Dohner, H., Stilgenbauer, S., James, M.R., Benner, A., Weilguni, T., Bentz, M., Fischer, K., Hunstein, W. and Lichter, P. (1997). 11q Deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood, 89, 2516-2522.
57. Neilson, J.R., Auer, R., White, D., Bienz, N., Waters, J.J., Whittaker, J.A., Milligan, D.W. and Fegan, C.D. (1997). Deletions at 11q identify a subset of patients with typical CLL who show consistent disease progression and reduced survival. Leukemia, 11, 1929-1932.
58. Oscier, D., Fitchett, M., Herbert, T. and Lambert, R. (1991). Karyotypic evolution in B-cell chronic lymphocytic leukaemia. Genes, Chromosomes and Cancer, 3, 16-20.
59. Raghoebier, S., Kibbelaar, R.E., Kleiverda, J.K., Kluin-Nelemans, J.C., van Krieken, J.H.J.M., Kok, F. and Kluin, Ph.M. (1992). Mosaicism of trisomy 12 in chronic lymphocytic leukemia detected by non-radioactive in situ hybridization. Leukemia, 6, 1220-1226.
60. Cuneo, A., Wlodarska, I., Sayed Aly, M., Piva, N., Carli, M.G., Fagioli, F., Tallarico, A., Pazzi, I., Ferrari, L., Cassiman, J.J., Van den Berghe, H. and Castoldi, G.L. (1992). Non-radioactive in situ hybridization for the detection and monitoring of trisomy 12 in B-cell chronic lymphocytic leukaemia. British Journal of Haematology, 81, 192-196.
61. Watanabe, T., Hotta, T., Ichikawa, A., Kinoshita, T., Nagai, H., Uchida, T., Murate, T. and Saito, H. (1994). The MDM2 oncogene overexpression in Chronic Lymphocytic Leukemia and low-grade lymphoma of B-cell origin. Blood, 84, 3158-3165.
62. Stilgenbauer, S., Döhner, H., Bulgay-Mörschel, M., Weitz, S., Bentz, M. and Lichter, P. (1993). High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics. Blood, 81, 2118-2124.
63. Liu, Y., Grander, D., Söderhäll, S., Juliusson, G., Gahrton, G. and Einhorn, S. (1992). Retinoblastoma gene deletions in B-cell chronic lymphocytic leukemia. Genes, Chromosomes and Cancer, 4, 250-256.
64. Liu, Y., Szekely, L., Grander, D., Söderhäll, S., Juliusson, G., Gahrton, G., Linder, S. and Einhorn, S. (1993). Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: evidence for a role of an adjacent locus. Proceedings of the National Academy of Science of the United States of America. 90, 8697-8701.
65. Garcia-Marco, J.A., Caldas, C., Price, C.M., Wiedemann, L.M., Ashworth, A. and Catovsky, D. (1996). Frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukemia. Blood, 88, 1568-1575.
66. Panayiotidis, P., Ganeshaguru, K., Rowntree, C., Jabbar, S.A.B., Hoffbrand, V.A. and Foroni, L. (1997). Lack of clonal BCRA2 gene deletion on chromosome 13 in chronic lymphocytic leukaemia. British Journal of Haematology, 97, 844-847.
67. Hanada, M., Delia, D., Aiello, A., Stadtmauer, E. and Reed, J.C. (1993). BCL-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood, 82, no 6, 1820-1828.
68. Lishner, M., Lalkin, A., Klein, A., Yarkoni, S., Manor, Y., Fejgin, M., Leytin, V., Ravid, M. and Amiel, A. (1995). The BCL-1, BCL-2 and BCL-3 oncogenes are involved in chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics, 85, 118-123.
69. Michaux, L., Mecucci, C., Stul, M., Wlodarska, I., Hernandez, J.M., Meeus, P., Michaux, J.L., Scheiff, J.M., Noël, H., Louwagie, A., Criel, A., Boogaerts, M., Van Orshoven, A., Cassiman, J.J. and Van den Berghe, H. (1996). BCL-3 rearrangement and t(14:19)(q32:q13) in lymphoproliferative disorders. Genes, Chromosomes and Cancer, 15, 38-47.
70. Döhner, H., Stilgenbauer, S., Fischer, K., Bentz, M. and Lichter, P. (1997). Cytogenetic and molecular cytogenetic analysis of B-cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes. Leukemia, 11, S19-S24.
71. Imamura, J., Miyoshi, I. and Koeffler, H.P. (1994), p53 in hematologic malignancies. Blood, 84, 2412-2421.
72. Döhner, H., Fischer, K., Bentz., M., Hansen, K., Benner, A., Cabot, G., Diehl, D., Schlenk, R., Coy, J., Stilgenbauer, S., Volkmann, M., Galle, P.R., Poustka, A., Hunstein, W. and Lichter, P. (1995). p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood, 85, 1580-1589.
73. Lens, D., Dyer, M., Garcia-Marco, J.M., De Schouwer, P.J.J., Hamoudi R.A., Jones, D., Farahat, N., Matutes and E. and Catovsky, D.(1997). p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis. British Journal of Haematology, 99, 848-857.
74. Schroeder, W.H. and Dighiero, G. (1994). The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunology Today, 15, 288-294.
75. Oscier, D.G., Thompsett, A., Zhu, D. and Stevenson, F.K. (1997). Differential rates of somatic hypermutation in Vh genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood, 89, 4153-4160.
76. H segments of Ig gene in Waldenström's macroglobulinemia and chronic lymphocytic leukemia (CLL) with Richter's syndrome but not in common CLL. Blood, 7, 1913-1919.
77. Cheson, B.D., Bennett, J.M., Grever, M., Kay, N., Keating, M.J., O'Brien, S. and Rai, K.R. (1996). National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood, 87, 4990-4997
78. Montserrat, E., Vinolas, N., Reverter, J.C. and Rozman, C. (1988). Natural history of chronic lymphocytic leukemia: on the progression and prognosis of early clinical stages. Nouvelle Revue Française d'Hématologie. 30, 359-361.
79. Rozman, C., Bosch, F. and Montserrat, E. (1997). Chronic lymphocytic leukemia: a changing natural history? Leukemia, 11, 775-778.
80. Bonato, M., Pittaluga, S., Tierens, A., Criel, A., Verhoef, G., Wlodarska, I., Vanutysel, L., Michaux, L., Vandekerckhove, P., Van den Berghe, H. and De Wolf-Peeters, C. (1998). Lymph node histology in typical and atypical chronic lymphocytic leukemia. The American Journal of Surgical Pathology, 22, 49-56.